We recently compiled a list of the Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025. In this article, we are ...

Shares opened higher by 71.4% and rallied as much as 77% shortly after the open. The stock has already traded more than 61 million shares this morning. Given its average trading volume of just under ...

Microbot Medical Inc. MBOT recently announced that it has entered into an agreement with Emory University, which is likely to allow the entities to evaluate and explore the potential for future ...

Fintel reports that on October 15, 2025, HC Wainwright & Co. reiterated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. Analyst Price Forecast Suggests 325.00% Upside As of ...

MICROBOT MEDICAL ($MBOT) is expected to release its quarterly earnings data on Tuesday, March 25th after market close, per Finnhub. Analysts are expecting revenue of ...

Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical ...

MBOT’s main value driver is its LIBERTY robot. This is a disposable, portable endovascular robot that has great potential. LIBERTY showed strong ACCESS-PVI data and now awaits FDA 510(k) clearance for ...